Albion Capital

Aridhia Informatics Ltd. is a Glasgow-based company that specializes in biomedical informatics and analytic solutions aimed at enhancing stratified medicine and translational research. Founded in 2007, Aridhia offers tools for patient tracking, infection control, and long-term condition management, along with clinical dashboards that provide at-a-glance information for healthcare professionals. The company focuses on integrating patient, clinical, and genomic data to improve the understanding, diagnosis, prevention, and treatment of chronic diseases. By collaborating with clinicians and researchers, Aridhia aims to empower patients to take a more active role in their healthcare while delivering insights into disease trends, risk factors, and treatment impacts to inform public health initiatives. Its partnerships with organizations like GoPivotal, Inc. and Glencoe Software, Inc. further bolster its innovative approach to addressing significant health challenges.

DYSIS Medical Ltd., established in 2002 and headquartered in Edinburgh, UK, specializes in designing, developing, manufacturing, and marketing non-invasive imaging systems for detecting cancerous and pre-cancerous lesions. Its flagship product is the DYSIS Colposcope, a digital colposcope that measures aceto-whitening reaction and generates an intuitive map for easier diagnosis. The company also offers accessories like disposable/reusable specula, diathermy loops, coagulation balls, and software for data management and DYSISmap development. With sales offices in Tampa (USA), Edinburgh (UK), and Athens (Greece), DYSIS Medical aims to improve healthcare outcomes globally.

Green Highland Renewables specializes in developing small-scale run-of-river hydroelectric projects ranging from 50kW to 2MW. The company provides comprehensive support to landowners and communities, from project design and procurement to operation, aiming to facilitate a sustainable future while contributing to Scotland's commitment to responsible climate change.

DYSIS Medical Ltd., established in 2002 and headquartered in Edinburgh, UK, specializes in designing, developing, manufacturing, and marketing non-invasive imaging systems for detecting cancerous and pre-cancerous lesions. Its flagship product is the DYSIS Colposcope, a digital colposcope that measures aceto-whitening reaction and generates an intuitive map for easier diagnosis. The company also offers accessories like disposable/reusable specula, diathermy loops, coagulation balls, and software for data management and DYSISmap development. With sales offices in Tampa (USA), Edinburgh (UK), and Athens (Greece), DYSIS Medical aims to improve healthcare outcomes globally.

Green Highland Renewables specializes in developing small-scale run-of-river hydroelectric projects ranging from 50kW to 2MW. The company provides comprehensive support to landowners and communities, from project design and procurement to operation, aiming to facilitate a sustainable future while contributing to Scotland's commitment to responsible climate change.

Green Highland Renewables specializes in developing small-scale run-of-river hydroelectric projects ranging from 50kW to 2MW. The company provides comprehensive support to landowners and communities, from project design and procurement to operation, aiming to facilitate a sustainable future while contributing to Scotland's commitment to responsible climate change.

DYSIS Medical Ltd., established in 2002 and headquartered in Edinburgh, UK, specializes in designing, developing, manufacturing, and marketing non-invasive imaging systems for detecting cancerous and pre-cancerous lesions. Its flagship product is the DYSIS Colposcope, a digital colposcope that measures aceto-whitening reaction and generates an intuitive map for easier diagnosis. The company also offers accessories like disposable/reusable specula, diathermy loops, coagulation balls, and software for data management and DYSISmap development. With sales offices in Tampa (USA), Edinburgh (UK), and Athens (Greece), DYSIS Medical aims to improve healthcare outcomes globally.

memsstar Limited is a leading provider of remanufacturing services for semiconductor equipment, specializing in etch and deposition technology for various applications, including MEMS and wafer fabrication. Founded in 2002 and based in Livingston, United Kingdom, the company remanufactures and refurbishes equipment, offering a range of proprietary solutions, such as the XERIC dry release etching module and the AURIX surface modification process module. Additionally, memsstar provides advanced platforms like ORBIS, which caters to institutions involved in MEMS research and development. The company is ISO 9001 certified and is recognized for its remanufacturing excellence, technology development, and extensive service capabilities. Through its innovative approach, memsstar aims to deliver high-quality, cost-effective solutions to the semiconductor manufacturing sector, enhancing process efficiency and supporting the development of MEMS technologies.